Gara Jalqabaatti › Leukemia Myeloidii Hamaa › Wisconsin › Milwaukee
Qorannoo klinikaalii Leukemia Myeloidii Hamaa Milwaukee, WI keessatti
Qorannoo 17 Leukemia Myeloidii Hamaa f Milwaukee fi naannoo isaa (kilomeetira 30 keessatti) hirmaatuu jiru. Qorannoo banaa eenyu akka hirmaatu fi akkamitti garee qorannoo akka quunnaman ilaali.
Takkalaa qorannoo (Ingiliffa)
Qorannoo hirmaatuu barbaadduu? Fuula kana jalatti agarsiisi — $99 guyyaa 30f →
MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
Namoota walitti qabaa jiraSadarkaa 2
- Aurora Cancer Care-Milwaukee, Milwaukee
- Aurora Saint Luke's Medical Center, Milwaukee
- Medical College of Wisconsin, Milwaukee
- fi 12 dabalataa
Ivosidenib as Post-HSCT Maintenance for AML
Namoota walitti qabaa jiraSadarkaa 2
- Froedtert Hospital & the Medical College of Wisconsin, Milwaukee
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Namoota walitti qabaa jiraQorannoo ilaalaaHojjettoota fayyaa simatamoo
- Aurora Cancer Care-Milwaukee, Milwaukee
- Aurora Saint Luke's Medical Center, Milwaukee
- Aurora Sinai Medical Center, Milwaukee
- fi 9 dabalataa
Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution
Namoota walitti qabaa jiraQorannoo ilaalaa
- Children's Hospital of Wisconsin, Milwaukee
Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidine in Younger Patients With Intermediate Risk AML (A MyeloMATCH Treatment Trial)
Namoota walitti qabaa jiraSadarkaa 2
- Medical College of Wisconsin, Milwaukee
Comparing New Treatments for People With Newly Diagnosed Acute Myeloid Leukemia That Has an IDH2 Gene Change (A MyeloMATCH Treatment Trial)
Namoota walitti qabaa jiraSadarkaa 2
- Medical College of Wisconsin, Milwaukee
Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)
Namoota walitti qabaa jiraSadarkaa 2
- Medical College of Wisconsin, Milwaukee
Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid Leukemia (AML) (A MyeloMATCH Treatment Trial)
Namoota walitti qabaa jiraSadarkaa 2
- Medical College of Wisconsin, Milwaukee
A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations
Namoota walitti qabaa jiraSadarkaa 3
- Children's Hospital of Wisconsin, Milwaukee
A Study of BGB-11417 in Participants With Myeloid Malignancies
Namoota walitti qabaa jiraSadarkaa 1/2
- Medical College of Wisconsin, Milwaukee
Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML
Namoota walitti qabaa jiraSadarkaa 3
- Froedtert & Medical College of Wisconsin, Milwaukee
Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia
Namoota walitti qabaa jiraSadarkaa 1
- Froedtert & Medical College Clinics, Milwaukee
ICP-248 in Combination With Azacitidine for the Treatment in Patients With Myeloid Malignancies
Namoota walitti qabaa jiraSadarkaa 1
- Medical College of Wisconsin, Milwaukee
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
Namoota walitti qabaa jiraQorannoo ilaalaa
- Children's Hospital of Wisconsin, Milwaukee
A Multi-phase Study of ASTX030 (Azacitidine and Cedazuridine) in Myeloid Neoplasm Alone or in Combination With Venetoclax in AML (AZTOUND Study)
Namoota walitti qabaa jiraSadarkaa 2/3
- Froedtert & Medical College of Wisconsin, Milwaukee
A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML
Namoota walitti qabaa jiraSadarkaa 1
- Medical College of Wisconsin Cancer Center, Milwaukee
Venetoclax to Augment Epigenetic Modification and Chemotherapy
Namoota walitti qabaa jiraSadarkaa 1
- Children's Wisconsin, Milwaukee
Qorannoo Leukemia Myeloidii Hamaa magaalota biroo keessatti
- Houston, TXQorannoo 85
- New York City, NYQorannoo 51
- Boston, MAQorannoo 44
- Seattle, WAQorannoo 41
- Baldwin Park, CAQorannoo 40
- Columbus, OHQorannoo 35
- Philadelphia, PAQorannoo 34
- Durham, NCQorannoo 33
- Atlanta, GAQorannoo 31
- Tampa, FLQorannoo 29
- Chicago, ILQorannoo 26
- Portland, ORQorannoo 25
Qorannoo biroo Milwaukee keessatti
- Saree OljooQorannoo 23
- Saree (Gosoota Hunda)Qorannoo 22
- Kansara Qara'a Non-Small CellQorannoo 22
- Myeloma Baay’eeQorannoo 21
- Dhibee QaraQorannoo 21
- Kansarii ProstateQorannoo 20
- Lymphoma FollicularQorannoo 19
- Non-Hodgkin LymphomaQorannoo 18
- Kansarii PancreasQorannoo 18
- Kansarii OvariiQorannoo 17
- Diffuse Large B-Cell LymphomaQorannoo 16
- Burkitt LymphomaQorannoo 16
Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.